Depression Clinical Trial
Official title:
The REFUGE-study: Health and Quality of Life Among Resettled Syrian Refugees and Asylum-seekers in Norway (REFUGE-I)
Brief summary The civil war in Syria has taken a severe toll on the Syrian population, with
over 350 000 dead and more than 10 million Syrians forced to leave their home since 2011. The
majority of the estimated 5.6 million Syrians who have left the country as refugees currently
reside in Syria's neighboring countries (Turkey, Jordan and Lebanon), while about 1 million
have fled to Europe. In the peak year of 2015, a little over 10500 Syrians applied for asylum
in Norway and an estimated 26 000 lived in the country at the start of 2018 according to
statistics from the Norwegian Directorate of Immigration.
Being a refugee or resettled refugee is psychologically stressful and increases the risk of
ill mental health. Prior research has demonstrated high to very high levels of posttraumatic
stress disorder (PTSD), depression and anxiety in refugees compared to normal populations. As
highlighted in prior review articles on the subject, there is a lack of studies on refugees
originating from the Middle Eastern countries, and there is a need for future studies on
refugee mental health to move beyond the focus on PTSD, depression and anxiety in order to
capture the wider psychological consequences associated with being a refugee or resettled
refugee. With the current number of displaced people globally approaching an unprecedented 70
million, including more than 25 million refugees, the need to understand and address the
health challenges in this population is more pressing than ever.
The present study, REFUGE-I, constitutes the first phase of a planned longitudinal cohort
study (REFUGE-study) on health and quality of life among resettled Syrian refugees in Norway.
The overarching aims of REFUGE-I are to recruit a representative sample of Syrian adults who
are willing to participate in the longitudinal cohort study and to obtain baseline
information on health-related topics as well as demographics for this recruited sample.
REFUGE-I will use a cross-sectional survey design. The study population will be a random and
representative sample of 10 000 Syrians over 18 years who arrived in Norway between 2015 and
2017, and who currently live and have a registered residential address in Norway. The sampled
group will be contacted and informed about the study through postal mail. Information about
the study will also be distributed through other channels: regular media (e.g. television and
newspapers), social media (e.g. Facebook), District Medical Doctors/Public Health Officers,
and a study web-page with more detailed information on the study including instructive
animation videos in Arabic. Those consenting to participate will be asked to fill out and
return a postal survey questionnaire on demographics and health-related topics focusing on:
Symptoms of posttraumatic stress, anxiety and depression Quality of life Self-reported
physical health (focusing on subjective pain) Sleep difficulties and alcohol consumption
patterns Social support Potentially traumatic experiences before or during the flight from
Syria Stress experienced after arrival in Norway (post-migratory stress)
Participants will also be asked whether the research group can contact them again for the
second and third phase of the longitudinal study, and informed that consent to participation
entails consent that survey data will be linked to Norwegian registry data on education, work
participation and sick-leave, drug prescriptions and utilization of the health-care system.
The registry data will be linked to survey data in the later phases of the larger
longitudinal study.
The main objective of the REFUGE-I study is to obtain and publish a thorough cohort profile
that includes descriptive statistics for the final sample on the above-listed health-related
topics, as well as information and statistics on potential selection bias issues that might
affect the generalizability of findings.
The study is a collaborative effort between five research institutions and universities in
Norway and Sweden. One of the collaborating partners, The Swedish Red Cross University
College, has already conducted a similar study on 1215 resettled adult Syrian refugees in
Sweden, and results from REFUGE-I will be compared to the findings from the Swedish study.
Moreover, an important long-term goal for the larger REFUGE-study is to help advance research
on refugees by making resources from the study available online, and through the creation of
a large database containing pooled data from the REFUGE-study and studies done through the
Swedish Red Cross University College and potentially other national and international
research groups.
Participants:
A complete list of potential participants meeting Inclusion criteria (see relevant section in
the submitted registration) was obtained in collaboration with the Norwegian National
Registry administered by the Norwegian Tax Administration. The complete list consisted of
14350 individuals which constituted the study's sampling frame. A simple random probability
sample of 10 000 individuals was selected from the sampling frame (sampling fraction = 0.7).
The actual sampling was conducted without any involvement from members of the REFUGE-I
research team.
Data collection:
All sampled participants will be sent a postal package to their registered residential
address in Norway. The package will contain a prepaid return envelope, the survey
questionnaire and a cover letter in Arabic describing the purpose of the study, its voluntary
nature, what potential participants can expect if they do participate, and how issues
surrounding confidentiality and anonymity will be handled. The cover letter also highlights
that survey data will be linked to registry data as part of the longitudinal study. Potential
participants will be enabled to give written informed consent to participation at the bottom
of the cover letter and instructed to enclose the written consent with the completed survey
questionnaire in the prepaid return envelope. Data from participants returning the
questionnaire without also submitting written consent to participation will be deleted in
accordance with agreements made with the Regional Committees for Medical and Health Research
Ethics (REC) - Region South East which granted the ethical approval for the study.
The survey questionnaire is eight pages long and expected to take about an hour to complete.
All instructions and questions in the questionnaire are in Arabic. Standard and pre-existing
scales in Arabic were used whenever available and Arabic translations were done by
professional translators in collaboration with an Arabic speaking reference group for
scales/items that did not already exist in Arabic. Potential participants will have about 8
weeks to complete and return the questionnaire with written consent. One postal reminder,
together with a blank copy of the survey questionnaire and a prepaid return envelope will be
sent out to participants who have not returned the questionnaire by a preset deadline - about
two weeks before the anticipated closing date for data collection (approximately January 15,
2019). This is in accordance with Norwegian rules and regulations governing research with
voluntary subjects which prohibits more than one reminder being sent out.
Analysis:
Three main articles are stipulated to be submitted for publication from the data collected
through the survey questionnaire of REFUGE-I. Article one will report descriptive statistics
on the main outcome variables: depression; anxiety; and symptoms of posttraumatic stress
disorder across key demographic and background variables in the sample, and describe the flow
of participants and discuss potential selection bias issues. Article two will provide
descriptive statistics on somatic pain, sleep difficulties and perceived general health, and
report findings across the same demographic and background variables as article one and
across the main outcomes of article one (depression, anxiety and symptoms of posttraumatic
stress disorder). Article three will present statistics on reported quality of life across
demographic and background variables, and across the outcome variables of article one and
two.
Alternatively, one larger article will be submitted for publication incorporating all of the
themes outlined in the three articles above.
Specific analysis plans for each article/theme are described below:
Article I:
Title: "Prevalence of common mental health disorders in adult Syrian refugees resettled in
Norway between 2015 and 2017: a cross-sectional survey questionnaire study".
In order to compare results to a parallel study on newly resettled adult refugees in Sweden
conducted by one of our collaborating institutions, Article I will use similar outcome and
predictor variables as this study. The main outcome variables will be:
Prevalence of symptom-based posttraumatic stress disorder (PTSD) as measured through the
first 16 items in the section on trauma symptoms (section IV) in the Harvard Trauma
Questionnaire (HTQ). A mean-item score ≥ 2.06 will define a "checklist-positive" PTSD case.
To be included in analyses, participants must have answered 14 or more of the 16 items on the
HTQ scale.
Prevalence of symptom-based depression and anxiety as measured through the two subscales on
depression and anxiety in the Hopkins Symptom Checklist (HSCL-25). A mean-item score ≥ 1.80
and ≥ 1.75 will define a "checklist-positive" depression and anxiety case, respectively. To
be included in analyses, participants must have answered ≥ 23 items on the 25-item scale.
The outcome variables above will be summarized for the whole sample population and across the
following demographic and background variables:
Gender Age; split into age groups: 18-29; 30-39; 40-49; 50-64; >64. Education; split into the
categories: 0-9 years; 10-12 years; >12 years Civil status; split into the categories:
Married; Unmarried; Divorced/separated/widow(er); Other Arrival status; split into the
categories: Asylum seeker; Quota/resettlement refugee; Family immigration; Other Year of
arrival/immigration to Norway; split into: 2015; 2016; 2017. Refugee trauma history measured
through the Refugee Trauma History Checklist (RTHC). The two scales contained in this
checklist will be combined - that is, the period will be "prior to arriving in Norway".
Post-migration stress measured through seven main items of the Post-migration stress scale
thought to tap into the relevant domains of post-migration stress. Answers to each item will
be dichotomized so that those answering "often" or "very often" are classified as having had
this reaction often (i.e. positive for that post-migratory stress reaction)
Prevalence estimates will be presented with 95% confidence intervals (95% CIs). Odds ratios
(ORs) with 95% CIs will be used when summarizing the main outcome variables across refugee
trauma history and post-migration stress. More specifically, the odds of having a
symptom-level above vs. below the preset cut-off value for the main outcomes will be
calculated for each binary (Y/N) item on the trauma history and post-migration stress scales
(eight and seven items for the two scales, respectively). The positive answer ("Yes") will
define exposed for each item when reporting the ORs.
In addition, descriptive statistics on the prevalence of refugee-related possible traumatic
events will be presented. Descriptive statistics (distribution, mean and variance) on the
seven domains of the complete 24-item post-migration scale will be presented and compared to
the study in Sweden. The prevalence of comorbidity between checklist-positive anxiety,
depression and PTSD will also be reported with 95% CIs.
The number of participants contributing data to a specific statistics will be reported. The
study will report, compare and discuss statistics on the participants vs. the sample frame on
all available parameters for both groups in order to evaluate selection bias issues
(anticipated available parameters include: age, gender, civil/marital status, permanent vs
temporary residence status, number of registered mobile phone numbers).
Article II:
Title: "Subjective health and pain, and sleep difficulties in adult Syrian refugees resettled
in Norway between 2015 and 2017: a cross-sectional survey questionnaire study".
Main outcomes:
Somatic pain (including pain in muscles and joints and general pain), measured as described
under Outcome Measures. Statistics on pain in muscles and joints will be aggregated (i.e. all
items will be combined) and reported as the percentage of participants in each of three
categories: Not troubled with pain in muscles and joints (Not troubled reported for all
items); Somewhat troubled with pain in muscles and joints (Somewhat troubled reported for at
least one item); Very troubled with pain in muscles and joints (Very troubled for at least
one item). Participants must have answered at least four of the five items (if all answers
are Not troubled), or Somewhat troubled/Very troubled on at least one item to be included in
analyses. Statistics on general pain will be presented in an identical manner (i.e. the
percentage in each of three categories, aggregated across all items on general pain) Sleep
difficulties, measured as described under Outcome Measures. The overall mean-item score will
be reported, as well as the estimated prevalence of insomnia, defined by the following
criteria: a score of 3 or above on at least one of the first 4 items + a score of 3 or higher
on at least one of the last 2 items. Participants must have answered at least five of the six
items to be included in analyses when analyzing the mean-item score of the scale. When
analyzing the prevalence of insomnia, participants must have answered at least three of the
first four items and one of the last two items; or, they must have a score of 3 or above on
at least one of the first four items and a score of 3 or above on at least one of the last
two items to be included in analyses.
Perceived general health, measured as described under Outcome Measures. Statistics on
perceived general health will be reported as the percentage of participants in each answer
category (with 95% CIs). Question one on overall health will be dichotomized with Very
good/Good as one category and the remaining three as one category (Don't know will not be
included). Question two on functional impairment will use all three answer categories (Don't
know will not be included).
The outcome variables above (with 95% CIs) will be presented for the whole sample combined,
and for the sample split on demographic and background variables 1-6 as outlined under the
description of article I above. In addition, the outcome variables will be presented across
the main outcome variables of article I: depression; anxiety; and PTSD (all binary).
Furthermore, perceived general health will be reported across outcome variable one: pain in
muscles and joints (3 categories) and general pain (3 categories); and outcome variable two:
sleep difficulties (binary - insomnia vs. not). The number of participants contributing data
to a specific statistics/analysis will be reported.
Article III:
Title: "Quality of life in adult Syrian refugees resettled in Norway between 2015 and 2017: a
cross-sectional survey questionnaire study".
The main outcome variable of Article III will be quality of life (QoL) measured through The
World Health Organization Quality of Life assessment (WHOQOL-BREF). All four domain-scores in
the scale (physical health; psychological health; social relationships; and environment) will
be used as outcome in analyses. In order to compare with relevant prior studies, the domain
scores will be converted as needed according to the method described by the WHO. That is,
results on quality of life will be presented in three different ways: as raw scores,
converted to a 4-20 scale, and converted to a 0-100 scale. In order to be included in
analysis for a certain domain, participants must have answered a minimum of six, five, two,
and six items for the domains: physical health, psychological health, social relationships,
and environment, respectively.
QoL scores (with standard deviation, SD, and 95% CIs) for the four domains will be presented
for the whole sample combined, and for the sample split on demographic and background
variables 1-6 as outlined under the description of article I above. In addition, QoL scores
(with SD and 95% CIs) will be presented across the main outcome variables of article I:
depression; anxiety; and PTSD (all binary); as well as the main outcome variables of article
II: muscle/joint pain and general pain, both variables split into three categories: Not
troubled (for all 5 items); Somewhat troubled (at least one item); Very troubled (at least
one item); sleep difficulties (binary - insomnia vs. not); and perceived general health
(binary for overall health, and three categories for functional impairment).
Furthermore QoL scores from REFUGE-I will be compared with scores from other refugee
populations, and with QoL scores in the general population around the world. The number of
participants contributing data to a specific statistics/analysis will be reported.
Ethical issues:
In the event that participation in the study triggers substantial adverse reactions in any of
the participants, a help-line will be set up by the research team in collaboration with
clinical personnel with experience on refugee mental health. Participants will be informed
that they can send a text message to the help-line's phone number, and that the clinical
personnel will call them back with an Arabic interpreter as soon as possible. Arrangements
will be made with a professional Norwegian interpreter firm to ensure the availability of an
interpreter within a reasonable time frame (hours). This service will be available during
regular work hours. During off-hours and weekends, participants will be instructed to contact
Norway's National out-of-hours medical service for immediate medical assistance and given the
necessary information on how to do so.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |